Jackson Health System Neuromuscular Medicine (Neurology)

Topics

• Amyotrophic Lateral Sclerosis Research 160
• Myasthenia Gravis and Thymoma 48
• Hereditary Neurological Disorders 37
• Peripheral Neuropathies and Disorders 26
• Multiple Sclerosis Research Studies 18
• Genetic Neurodegenerative Diseases 10
• Botulinum Toxin and Related Neurological Disorders 9
• Muscle Physiology and Disorders 8
• Peripheral Nerve Disorders 6
• Amyloidosis: Diagnosis, Treatment, Outcomes 4
• CNS Lymphoma Diagnosis and Treatment 4
• Neurogenetic and Muscular Disorders Research 4

Most cited

1. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.

   The New England journal of medicine · 2022 · 755 citations · Michael Benatar

2. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update.

   Neurology · 2021 · 575 citations · Michael Benatar

3. From cohorts to molecules: Adverse impacts of endocrine disrupting mixtures.

   Science (New York, N.Y.) · 2022 · 267 citations · Alejandro Tobon

4. Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia.

   The New England journal of medicine · 2023 · 217 citations · Mario Saporta

5. Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study.

   The Lancet. Neurology · 2023 · 236 citations · Michael Benatar

6. A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis.

   The New England journal of medicine · 2025 · 51 citations · Michael Benatar

7. Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention.